ExodusPoint Capital Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $105K | Sell |
13,988
-21,212
| -60% | -$159K | ﹤0.01% | 1284 |
|
2025
Q1 | $266K | Buy |
35,200
+11,700
| +50% | +$88.4K | ﹤0.01% | 1191 |
|
2024
Q4 | $286K | Buy |
+23,500
| New | +$286K | ﹤0.01% | 1177 |
|
2024
Q2 | – | Sell |
-16,347
| Closed | -$279K | – | 1435 |
|
2024
Q1 | $279K | Sell |
16,347
-13,290
| -45% | -$227K | ﹤0.01% | 1154 |
|
2023
Q4 | $302K | Sell |
29,637
-6,122
| -17% | -$62.4K | ﹤0.01% | 1107 |
|
2023
Q3 | $324K | Sell |
35,759
-3,402
| -9% | -$30.8K | ﹤0.01% | 1350 |
|
2023
Q2 | $421K | Sell |
39,161
-4,991
| -11% | -$53.7K | ﹤0.01% | 1329 |
|
2023
Q1 | $452K | Buy |
+44,152
| New | +$452K | ﹤0.01% | 1270 |
|